Annales De Dermatologie Et De Venereologie最新文献

{"title":"Tele-expertise assessment of chronic wounds by advanced practice dermatology nurses","authors":"C. Robin , L. Poiroux , J. Delaunay , P. Seuwou , L. Martin , E. Démoulins","doi":"10.1016/j.annder.2024.103273","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103273","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103273"},"PeriodicalIF":0.9,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0151963824000292/pdfft?md5=84e1cf24c2543da4de2d3d7ac70ae02d&pid=1-s2.0-S0151963824000292-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140650912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A rare case of granular parakeratosis of the glans resembling genital psoriasis","authors":"A. Badaoui, I. Moulonguet","doi":"10.1016/j.annder.2024.103268","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103268","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103268"},"PeriodicalIF":0.9,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140807041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Electrosurgery in the treatment of pedunculated rhinophyma","authors":"M. Dultra, P. Barros, A. Ivanchuk, J.R. Pegas","doi":"10.1016/j.annder.2024.103270","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103270","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103270"},"PeriodicalIF":0.9,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140649776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-life management of psoriasis with biological agents during pregnancy","authors":"C. Tran ,&nbsp;E. Mahé ,&nbsp;M. Beylot-Barry ,&nbsp;D. Jullien ,&nbsp;M.-A. Richard ,&nbsp;A.-C. Fougerousse ,&nbsp;A. Bouznad ,&nbsp;C. Bulai Livideanu ,&nbsp;A. Brun ,&nbsp;F. Amelot ,&nbsp;F. Maccari ,&nbsp;F. Aubin ,&nbsp;F. Benhadou ,&nbsp;C. Paul","doi":"10.1016/j.annder.2024.103254","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103254","url":null,"abstract":"<div><h3>Background</h3><p>French guidelines recommend stopping biologic treatment of psoriasis between 3 and 24 weeks before conception in accordance with the relevant Summary of Product Characteristics (SmPC). The aim of this study was to evaluate the real-life practice of dermatologists in the management of pregnant women with psoriasis previously treated with biologic agents. We wished to assess the level of practitioner adherence to the relevant SmPCs.</p></div><div><h3>Material and methods</h3><p>We conducted a study in collaboration with GRPso and Resopso. A computerized questionnaire was completed by the practitioners. We performed descriptive statistics and studied the profile of the practitioners, their level of confidence with continuation of biological agents during pregnancy, and their reported practices on the use of biological agents in pregnancy. Statistical analyses were performed using XLSTAT. A p-value of less than 0.05 was considered significant.</p></div><div><h3>Results</h3><p>A total of 63 dermatologists (women: 71%; mean age 43.8 years) participated in this study, the majority of whom were hospital-based (87%). Recommendations were followed by 36.5% of practitioners, while 44% reported discontinuing biologic agents on diagnosis of pregnancy, and 20.5% reported using these agents during pregnancy. Among dermatologists with more than ten years of experience, 19% reported following the SmPC. Among dermatologists with a patient base &gt;200 (patients treated with biologic agents for psoriasis), 19% reported following the SmPC compared to 54% of practitioners with less than 50 patients. The mean age of dermatologists following the SmPC was 41 years vs. 47 years for those not following the SmPC.</p></div><div><h3>Discussion</h3><p>The majority of practitioners do not follow recommendations on discontinuation of biologic agents before the planning of pregnancy by patients.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103254"},"PeriodicalIF":0.9,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140328083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evolution of rituximab use over time in moderate-to-severe pemphigus: A two-centre retrospective study","authors":"M. Hazard,&nbsp;C. Bedane,&nbsp;O. Ducharme,&nbsp;P. Bernard,&nbsp;A.-L. Pham-Ledard","doi":"10.1016/j.annder.2024.103265","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103265","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103265"},"PeriodicalIF":0.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pemphigoid of the pulmonary system","authors":"A.R. Ahmed,&nbsp;M. Kalesinskas","doi":"10.1016/j.annder.2024.103253","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103253","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103253"},"PeriodicalIF":0.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients","authors":"A. Louchez ,&nbsp;T. El Aarbaoui ,&nbsp;A. Weill ,&nbsp;O. Gaudin ,&nbsp;L. Jelti ,&nbsp;T. Belmondo ,&nbsp;P. Wolkenstein ,&nbsp;S. Ingen-Housz-Oro","doi":"10.1016/j.annder.2024.103264","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103264","url":null,"abstract":"<div><h3>Background</h3><p>Following the RITUX 3 therapeutic trial, the French national diagnosis and care protocol (NDCP) for the treatment of pemphigus was updated in 2018. The updated protocol recommends initial treatment with rituximab (RTX) followed by maintenance therapy at 12 and 18 months, and potentially at 6 months where there are risk factors for early relapse. We evaluated these recommendations regarding the management of our own patients.</p></div><div><h3>Patients and Methods</h3><p>Our single-center retrospective study included all patients with pemphigus diagnosed between 01/2015 and 10/2020 and receiving at least one initial infusion of RTX. We collected the following data: type of pemphigus, severity, levels of anti-desmoglein 1 and 3 antibodies at diagnosis and between 2 and 6 months after initial RTX, presence or absence of maintenance therapy and modalities, time to first relapse and duration of associated systemic corticosteroid therapy ≥5 mg/day. Maintenance treatment modalities were as follows: no maintenance treatment, maintenance “on demand” (MT1) <em>i.e.</em> not performed at the rate imposed by the NDCP, and maintenance “according to NDCP” (MT2).</p></div><div><h3>Results</h3><p>Fifty patients were included (women 54%, median age 58 years, pemphigus vulgaris 68%, moderate to severe 68%). Initial RTX was combined with systemic corticosteroid therapy at 0.5 to 1 mg/kg in 74% of cases. Twenty-seven patients (54%) received no maintenance therapy, 13 were on an MT1 regimen (26%), and 10 were on an MT2 regimen (20%). Median follow-up was 42 months. At the last follow-up, 39 patients (78%) were in complete remission. A total of 25 patients (50%) relapsed: 18/27 (67%) patients without maintenance, 5/13 (38%) with MT1, and 2/10 (20%) with MT2 (<em>p</em> = 0.026). The probability of relapse over time was significantly lower in patients receiving maintenance therapy compared to those who receiving none (<em>p</em> = 0.022). The median time to relapse was 15 months in patients without maintenance, and 30 and 28 in those with maintenance (<em>p</em> = 0.27). The median duration of systemic corticosteroid therapy ≥ 5 mg/day in the no-maintenance group was 10 months, compared to 7 and 9 months respectively in MT1 and MT2 (<em>p</em> = 0.91).</p></div><div><h3>Conclusion</h3><p>Our study confirms the value of RTX maintenance therapy in pemphigus in real life.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103264"},"PeriodicalIF":0.9,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resolution of refractory single-nail psoriasis through a single session of fractional CO2 laser-asssited methotrexate delivery","authors":"B. Soutou ,&nbsp;J. Kaikati ,&nbsp;R. Afiouni,&nbsp;R. Jabbour,&nbsp;S. Skaff,&nbsp;J Abou Khater,&nbsp;J. Helou","doi":"10.1016/j.annder.2024.103255","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103255","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103255"},"PeriodicalIF":0.9,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140180849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retaining dermatology patients in primary care through dialogue with secondary care providers: A service evaluation","authors":"J. Brainard ,&nbsp;A. Crawford ,&nbsp;B. Wright ,&nbsp;M. Lim ,&nbsp;P. Everden","doi":"10.1016/j.annder.2024.103248","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103248","url":null,"abstract":"<div><h3>Background</h3><p>There are long patient waiting lists for specialist care. A dermatology dialogue service between primary and secondary care (DDPS) was developed in eastern England. Primary care referrers uploaded patient images of skin conditions for review by and dialogue with consultant dermatologists in an attempt to retain patients in primary care rather than refer them to secondary care.</p></div><div><h3>Methods</h3><p>Evaluation of service performance against specific targets, including reduction in secondary care waiting list growth over the period April 2021–March 2022 inclusive. Service activity was summarized in terms of speed of resolution, case numbers, and dispositions. Clinician and patient satisfaction were assessed using structured questionnaires. Actual numbers of new referrals were compared to projections based on historical data. Waiting list growth was compared to other specialties and other commissioning areas. Waiting times to initial treatment were monitored.</p></div><div><h3>Results</h3><p>Over 3300 patients were enrolled and &gt; 90% of dialogues were resolved within 36 hours. Clinician and patient satisfaction were high. Frequently asked questions and conditions were highlighted by dermatologists to design and deliver an educational event for primary care clinicians that was well received. Waiting list growth for dermatology patients in the commissioning area was smaller than for other major specialties, and generally smaller than growth for dermatology waiting lists commissioned by other NHS commissioners. There was no negative impact on the urgent priority (cancer pathway) waiting list.</p></div><div><h3>Conclusion</h3><p>The DDPS was satisfactory for clinicians and patients and coincided with lower growth in dermatology waiting lists than might otherwise have been expected.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103248"},"PeriodicalIF":0.9,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0151963824000048/pdfft?md5=a2e26bab035b177309de519f6fc54fc4&pid=1-s2.0-S0151963824000048-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140163817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient","authors":"T. Randriamiarana,&nbsp;D. Boutin,&nbsp;A. Thierry,&nbsp;J.-C. Lecron,&nbsp;E. Hainaut,&nbsp;M. Masson Regnault","doi":"10.1016/j.annder.2024.103259","DOIUrl":"https://doi.org/10.1016/j.annder.2024.103259","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 2","pages":"Article 103259"},"PeriodicalIF":0.9,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140163745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}